This study is also the first to report consistent decreases in Act-AB with CRC progression and the protein induced cell cycle arrest and increased the markers of apoptosis in the SW480 and HT29 cells, implying that it could act as a Smad4-independent tumour suppressor. This evidence concerns the gene SMAD4 and neoplasm.